Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-18 3:37 pm Purchase | 2025-02-11 | 13G | Aramark ARMK | Farallon Capital Partners, L.P. | 13,638,340 5.100% | 2,001,403 (+17.20%) | Filing History |
| 2025-02-18 3:36 pm Purchase | 2025-02-11 | 13G | The New York Times Company NYT | Farallon Capital Partners, L.P. | 9,011,576 5.500% | 1,635,463 (+22.17%) | Filing History |
| 2025-02-11 5:14 pm Purchase | 2024-12-31 | 13G | Savara Inc. SVRA | Farallon Capital Partners, L.P. | 18,288,986 9.990% | 526,453 (+2.96%) | Filing History |
| 2025-02-11 12:11 pm Purchase | 2024-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Farallon Capital Partners, L.P. | 2,108,262 9.900% | 83,262 (+4.11%) | Filing History |
| 2025-02-10 2:33 pm Purchase | 2024-12-31 | 13G | ALEANNA INC ANNA | Farallon Capital Partners, L.P. | 1,068,400 2.600% | 1,068,400 (New Position) | Filing History |
| 2025-02-10 12:47 pm Purchase | 2024-12-31 | 13G | Forte Biosciences, Inc. FBRX | Farallon Capital Partners, L.P. | 221,027 3.400% | 69,287 (+45.66%) | Filing History |
| 2025-02-10 09:00 am Purchase | 2024-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | Farallon Capital Partners, L.P. | 5,956,488 9.990% | 191,379 (+3.32%) | Filing History |
| 2025-02-05 7:30 pm Purchase | 2024-12-31 | 13G | Beam Therapeutics Inc. BEAM | Farallon Capital Partners, L.P. | 8,239,123 9.900% | 31,000 (+0.38%) | Filing History |
| 2025-02-05 5:23 pm Sale | 2024-12-31 | 13G | The New York Times Company NYT | Farallon Capital Partners, L.P. | 7,376,113 4.500% | -2,100,678 (-22.17%) | Filing History |
| 2025-02-05 4:28 pm Unchanged | 2024-12-31 | 13G | Elevation Oncology, Inc. ELEV | Farallon Capital Partners, L.P. | 3,527,482 6.000% | 0 (Unchanged) | Filing History |
| 2025-02-05 1:10 pm Purchase | 2024-12-31 | 13G | Perspective Therapeutics, Inc. CATX | Farallon Capital Partners, L.P. | 5,316,227 7.600% | 252,000 (+4.98%) | Filing History |
| 2025-02-04 12:02 pm Purchase | 2024-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | Farallon Capital Partners, L.P. | 5,674,466 9.900% | 13,600 (+0.24%) | Filing History |
| 2024-11-14 8:21 pm Purchase | 2024-11-08 | 13G | Perspective Therapeutics, Inc. CATX | Farallon Capital Partners, L.P. | 5,064,227 7.300% | 5,064,227 (New Position) | Filing History |
| 2024-11-08 5:15 pm Purchase | 2024-09-30 | 13G | Longboard Pharmaceuticals, Inc. LBPH | Farallon Capital Partners, L.P. | 3,456,063 9.990% | 1,250,073 (+56.67%) | Filing History |
| 2024-11-08 2:57 pm Sale | 2024-09-30 | 13G | Aramark ARMK | Farallon Capital Partners, L.P. | 11,636,937 4.400% | -5,262,317 (-31.14%) | Filing History |
| 2024-11-08 2:40 pm Purchase | 2024-09-30 | 13G | Agios Pharmaceuticals, Inc. AGIO | Farallon Capital Partners, L.P. | 5,660,866 9.900% | 1,493,264 (+35.83%) | Filing History |
| 2024-11-08 11:54 am Purchase | 2024-09-30 | 13G | Elevation Oncology, Inc. ELEV | Farallon Capital Partners, L.P. | 3,527,482 6.000% | 427,482 (+13.79%) | Filing History |
| 2024-11-07 09:56 am Purchase | 2024-09-30 | 13G | Beam Therapeutics Inc. BEAM | Farallon Capital Partners, L.P. | 8,208,123 9.900% | 4,102,370 (+99.92%) | Filing History |
| 2024-11-06 6:32 pm Purchase | 2024-09-30 | 13G | Savara Inc. SVRA | Farallon Capital Partners, L.P. | 17,762,533 9.990% | 3,435,622 (+23.98%) | Filing History |
| 2024-11-06 5:06 pm Sale | 2024-09-30 | 13G | Swiftmerge Acquisition Corp. IVCP | Farallon Capital Partners, L.P. | 471,366 9.900% | -53,634 (-10.22%) | Filing History |